Silk Road Medical, Inc (SILK)

Market Cap	1.07B
Revenue (ttm)	185.49M
Net Income (ttm)	-53.67M
Shares Out	39.72M
EPS (ttm)	-1.38
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,133,772
Open	26.97
Previous Close	26.95
Day's Range	26.93 - 27.05
52-Week Range	6.08 - 33.13
Beta	1.51
Analysts	Hold
Price Target	21.72 (-19.62%)
Earnings Date	Jul 30, 2024

About SILK

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid arte...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Apr 4, 2019
• Employees: 474
• Stock Exchange: NASDAQ
• Ticker Symbol: SILK

Financial Performance

In 2023, SILK's revenue was $177.13 million, an increase of 27.77% compared to the previous year's $138.64 million. Losses were -$55.74 million, 1.33% more than in 2022.

Analyst Forecast

According to 11 analysts, the average rating for SILK stock is "Hold." The 12-month stock price forecast is $21.72, which is a decrease of -19.62% from the latest price.

Price Target

$21.72

(-19.62% downside)

Analyst Consensus: Hold